322 related articles for article (PubMed ID: 11362921)
1. New trials reach same conclusion: two drugs are better than AZT alone.
AIDS Alert; 1995 Nov; 10(11):133-6. PubMed ID: 11362921
[TBL] [Abstract][Full Text] [Related]
2. ACTG 175 and Delta.
Torres G
GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
[TBL] [Abstract][Full Text] [Related]
3. Studies confirm value of early and combination treatments.
Vazquez E
Posit Aware; 1995; VI(6):8. PubMed ID: 11363148
[TBL] [Abstract][Full Text] [Related]
4. Study results at a glance.
AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
[TBL] [Abstract][Full Text] [Related]
5. Making sense of 175 and Delta.
Smart T
GMHC Treat Issues; 1995 Oct; 9(10):4. PubMed ID: 11362916
[TBL] [Abstract][Full Text] [Related]
6. AZT delta study: major European/Australian study finds combinations better than AZT alone.
King E
AIDS Treat News; 1995 Oct; (no 232):3-4. PubMed ID: 11362876
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy increases survival.
Treat Rev; 1995 Nov; (no 20):2-3. PubMed ID: 11363019
[TBL] [Abstract][Full Text] [Related]
8. ACTG 175: new insights into treating patients with intermediate-stage HIV disease.
Folkers G
NIAID AIDS Agenda; 1995 Dec; ():4-5. PubMed ID: 11363352
[TBL] [Abstract][Full Text] [Related]
9. To treat or not to treat--approaches to antiretroviral therapy. Interview by Anthony J. Japour.
Coombs R; Cotton D; Hammer S; Saag M; van der Horst C
AIDS Clin Care; 1996 Jan; 8(1):1-4. PubMed ID: 11363056
[TBL] [Abstract][Full Text] [Related]
10. AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration.
James JS
AIDS Treat News; 1996 Apr; (no 244):6. PubMed ID: 11363307
[TBL] [Abstract][Full Text] [Related]
11. Can the conundrums of ACTG 175 be solved? An interview with Martin S. Hirsch, MD.
Hirsch MS
J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):29-30. PubMed ID: 11362965
[TBL] [Abstract][Full Text] [Related]
12. AZT studies reinforce benefits of combination.
AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
[TBL] [Abstract][Full Text] [Related]
13. Benefits of combination therapy confirmed.
Cheng B
PI Perspect; 1995 Dec; (no 17):3-4. PubMed ID: 11363111
[TBL] [Abstract][Full Text] [Related]
14. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
James JS
AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
[TBL] [Abstract][Full Text] [Related]
15. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
[TBL] [Abstract][Full Text] [Related]
16. AZT combination trial shows positive results.
Nature; 1995 Sep; 377(6547):277. PubMed ID: 7566074
[No Abstract] [Full Text] [Related]
17. [Results of two studies: Delta I/II and ACTG 175].
Biehler GV
Sidahora; 1996 Dec-1997 Jan; ():37-40. PubMed ID: 11363441
[TBL] [Abstract][Full Text] [Related]
18. Closing the circle on HIV--or not.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):10-4, 17-29 contd. PubMed ID: 11362964
[TBL] [Abstract][Full Text] [Related]
19. Back to the nukes.
Smart T
GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
[TBL] [Abstract][Full Text] [Related]
20. Top AIDS researchers' strategy for antiretroviral treatment.
AIDS Alert; 1996 Sep; 11(9):97-100. PubMed ID: 11363728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
